Dianthus Therapeutics
DNTH • NASDAQ
Dianthus Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Marino Garcia, with a market cap of $4.3B.
Market Cap$4.3B
Employees53.0
CEOMarino Garcia
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · in a monthQ1 2026
Financials
Dianthus Therapeutics FAQ
Common questions about Dianthus Therapeutics
Dianthus Therapeutics is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $435.2K.
Dianthus Therapeutics has approximately 53 employees.